AstraZeneca CEO says Summit drug could drive next generation of cancer combinations

October 5, 2026 admin

• Facebook
• Twitter
• Pinterest

CNBC TelevisionMon, October 5, 2026 10:42pmURL:
Embed:

AstraZeneca CEO Pascal Soriot told CNBC that Summit Therapeutics’ lead drug could help power next-generation cancer combinations that could be the “future of cancer care.”

CNBC’s Annika Kim Constantino has the latest.

• Facebook
• Twitter
• Pinterest

Related posts

• 

  October 5, 2026 admin 0

  McHenry Says Debt Fight Could Hit Treasuries Harder

  Bloomberg TelevisionMon, October 5, 2026 10:43pmURL:Embed:Patrick McHenry, Former House Financial Services Chair, says Republicans are playing...

  Business 

• 

  October 5, 2026 admin 0

  Conley: Refined Fuels Remain The Energy Problem

  Bloomberg TelevisionMon, October 5, 2026 10:43pmURL:Embed:Heather Conley, senior fellow at AEI, a senior advisor at Evenflow...

  Business 

• 

  October 5, 2026 admin 0

  Is AI safety even a solvable problem? The White House’s new AI czar and Sam Altman’s comments

  Yahoo FinanceMon, October 5, 2026 10:42pmURL:Embed:Is AI safety even a solvable problem? Sherwood News Head of...

  Business